Sunday, July 09, 2023 5:52:55 PM
Will they wear something like this for over 18 hours a day? All the investors just need common sense to know the answer.
Dendritic cells after be activated and maturated by poly-iclc have maximum seven days life after migrating to lymph nodes. Three doses will be administered within 28 days. After 35 days, all the primed dendritic cells loaded tumor antigen are gone. Yet the anti-tumor response continues. How is that? Dr. Bosch said the following.
Is it coincident that the C-suite of NVCR has been dumping their share ever since the first paper of p3 DCVax-L clinical trial were published in May 2018? The answer is no.
Six hundred patients already received DCVax-L, among which at least two hundreds were through the special program. It is just because of many patients that Professor Ashkan treated with DCVax-L that gave him the confidence that three doses of DCVax-L is enough to prime the immune system. So what are you waiting for?
Recent NVCR News
- Novocure to Report Third Quarter 2024 Financial Results • Business Wire • 10/01/2024 11:00:00 AM
- Novocure to Present Real-World Data at ESMO 2024 Demonstrating Improved Survival Outcomes for Newly Diagnosed Glioblastoma Patients with Increased Use of Tumor Treating Fields (TTFields) Therapy • Business Wire • 09/09/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 11:00:17 AM
- Novocure Announces Planned CEO Transition • Business Wire • 09/03/2024 11:00:00 AM
- Novocure to Participate in 2024 Wells Fargo Healthcare Conference • Business Wire • 08/28/2024 11:00:00 AM
- Novocure Highlights TTFields Therapy in Treatment of Non-Small Cell Lung Cancer at 2024 World Conference on Lung Cancer • Business Wire • 08/14/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:22:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:19:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:19:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:17:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:16:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 08:25:19 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 07/25/2024 12:25:38 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/25/2024 11:05:37 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 11:01:22 AM
- Novocure Reports Second Quarter 2024 Financial Results • Business Wire • 07/25/2024 11:00:00 AM
- Novocure to Report Second Quarter 2024 Financial Results • Business Wire • 07/01/2024 11:00:00 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM